132 related articles for article (PubMed ID: 21750291)
1. Mortality in chronic kidney disease and mineral metabolism.
Floege J; Kronenberg F; Froissart M
JAMA; 2011 Jul; 306(2):159; author reply 159-60. PubMed ID: 21750291
[No Abstract] [Full Text] [Related]
2. Mineral metabolism disturbances in patients with chronic kidney disease.
Kestenbaum B; Belozeroff V
Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid function after kidney allografting.
Tajima A; Ishikawa A; Ohta N; Suzuki K; Kawabe K; Aso Y
Transplant Proc; 1996 Jun; 28(3):1629-30. PubMed ID: 8658814
[No Abstract] [Full Text] [Related]
4. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.
Palmer SC; Hayen A; Macaskill P; Pellegrini F; Craig JC; Elder GJ; Strippoli GF
JAMA; 2011 Mar; 305(11):1119-27. PubMed ID: 21406649
[TBL] [Abstract][Full Text] [Related]
5. [Hyrparathyroidism in renal insufficiency treated by hemodialysis and transplantation].
Zech P; Perinetti M; Moskovtchenko JF; Pozet N; Meunier P; Traeger J
Rein Foie; 1970; 13():223-50. PubMed ID: 4926838
[No Abstract] [Full Text] [Related]
6. Plasma parathormone, calcium and phosphorus in patients with renal osteodystrophy undergoing chronic hemodialysis.
Genuth SM; Sherwood LM; Vertes V; Leonards JR
J Clin Endocrinol Metab; 1970 Jan; 30(1):138-40. PubMed ID: 5409532
[No Abstract] [Full Text] [Related]
7. Calcium phosphorus metabolism in dialysis patients with and without mitral anular calcium. Analysis of 30 patients.
Nestico PF; DePace NL; Kotler MN; Rose LI; Brezin JH; Swartz C; Mintz GS; Schwartz AB
Am J Cardiol; 1983 Feb; 51(3):497-500. PubMed ID: 6823866
[No Abstract] [Full Text] [Related]
8. CKD-MBD: comfort in the trough of the U.
Cunningham J; Silver J
Nephrol Dial Transplant; 2011 Jun; 26(6):1764-6. PubMed ID: 21551089
[No Abstract] [Full Text] [Related]
9. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
[TBL] [Abstract][Full Text] [Related]
10. Cinacalcet hydrochloride in chronic kidney disease-mineral bone disorder.
Yokoyama K
Clin J Am Soc Nephrol; 2009 Sep; 4(9):1405-8. PubMed ID: 19696214
[No Abstract] [Full Text] [Related]
11. Digital manifestations of tertiary hyperparathyroidism.
Thomas LF; McCarthy JT; Wenger DE; Norby SM
Kidney Int; 2012 Sep; 82(6):724. PubMed ID: 22935883
[No Abstract] [Full Text] [Related]
12. Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product.
Moe SM; Drüeke TB
Am J Nephrol; 2003; 23(6):369-79. PubMed ID: 14551461
[TBL] [Abstract][Full Text] [Related]
13. Mineral metabolism disorders in chronic kidney disease.
Kestenbaum B
JAMA; 2011 Mar; 305(11):1138-9. PubMed ID: 21406655
[No Abstract] [Full Text] [Related]
14. Parathyroid hormone suppression by cimetidine in the uremic patient.
Beehler CJ; Beckner JR; Rosenquist RC; Shankel SW
Ann Intern Med; 1980 Dec; 93(6):840-1. PubMed ID: 7447192
[No Abstract] [Full Text] [Related]
15. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.
Block GA; Klassen PS; Lazarus JM; Ofsthun N; Lowrie EG; Chertow GM
J Am Soc Nephrol; 2004 Aug; 15(8):2208-18. PubMed ID: 15284307
[TBL] [Abstract][Full Text] [Related]
16. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
Mehrotra R
J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
[TBL] [Abstract][Full Text] [Related]
17. Chronic kidney disease: Levels of phosphorus and patient outcomes.
Foley RN
Nat Rev Nephrol; 2011 Jun; 7(8):428-30. PubMed ID: 21712850
[No Abstract] [Full Text] [Related]
18. Early dietary phosphorus restriction and calcium supplementation in the prevention of renal osteodystrophy.
Maschio G; Tessitore N; D'Angelo A; Bonucci E; Lupo A; Valvo E; Loschiavo C; Fabris A; Morachiello P; Previato G; Fiaschi E
Am J Clin Nutr; 1980 Jul; 33(7):1546-54. PubMed ID: 7395775
[No Abstract] [Full Text] [Related]
19. Secondary hyperparathyroidism: review of the disease and its treatment.
de Francisco AL
Clin Ther; 2004 Dec; 26(12):1976-93. PubMed ID: 15823762
[TBL] [Abstract][Full Text] [Related]
20. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
[No Abstract] [Full Text] [Related]
[Next] [New Search]
